← Back to Search

Asthma patients for Asthma

N/A
Recruiting
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial aims to investigate if asthma patients and their doctors are willing to switch inhalers for environmental reasons. Metered dose inhalers have a bigger carbon footprint than dry powder inhalers, so the study

Who is the study for?
This trial is for adults over 18 with confirmed asthma, treated at the Montreal Chest Institute or Montreal General Hospital. Participants must be on inhaled steroids and Ventolin MDI, have stable asthma without recent ER visits, and sufficient lung function to use both DPI and MDI inhalers.Check my eligibility
What is being tested?
The study aims to evaluate if asthma patients are willing to switch inhalers due to environmental concerns. It will also assess their awareness of the climate impact of different types of inhalers (MDI vs DPI) and factors influencing their choice.See study design
What are the potential side effects?
Since this is an educational intervention rather than a medical treatment, traditional side effects are not expected. However, participants may experience changes in perception regarding their health choices' environmental impact.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rotation of Ventolin MDI to Bricanyl Turbuhaler.
Secondary outcome measures
Awareness of patients regarding the climate impact of inhalers
Patients' willingness to change inhalers for environmental reasons
Proportion of patients who filled Bricanyl Rx change
+2 more

Side effects data

From 2018 Phase 4 trial • 320 Patients • NCT03068897
4%
Gastrointestinal complaint
3%
Drowsiness
1%
dizziness
100%
80%
60%
40%
20%
0%
Study treatment Arm
Metaxalone
Baclofen
Placebo
Tizanidine

Trial Design

1Treatment groups
Experimental Treatment
Group I: Asthma patientsExperimental Treatment1 Intervention
Low risk educational intervention. The consented patients will be given an information packet containing an infographic about the climate impact of inhalers, a letter explaining the option of changing inhalers (which clearly outlines that the Bricanyl Turbuhaler will not cost them more money than the Ventolin) and a pre-filled prescription for Bricanyl Turbuhaler. Also 5 selected asthma providers will be asked to fill a questionnaire on their perspectives on the climate impact of inhalers and their approach to inhaler rotation. This may also be supplemented with a phone interview
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational intervention
2018
Completed Phase 4
~15170

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
450 Previous Clinical Trials
159,746 Total Patients Enrolled
4 Trials studying Asthma
732 Patients Enrolled for Asthma
~63 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top